Cargando…
Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications
Autores principales: | Akiyode, Oluwaranti, Tran, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755448/ https://www.ncbi.nlm.nih.gov/pubmed/26912965 http://dx.doi.org/10.2337/diaspect.29.1.44 |
Ejemplares similares
-
Case Study: Use of GLP-1 Receptor Agonist in a Patient on Intensive Insulin Therapy
por: Wiley, Kenneth Calvin, et al.
Publicado: (2015) -
Anti-Vascular Endothelial Growth Factor Agents for Ocular Angiogenesis and Vascular Permeability
por: Kubota, Toshiaki, et al.
Publicado: (2012) -
Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013) -
Results of the Epidemiology of Diabetes Interventions and Complications Trial
por: Wright, Eugene E.
Publicado: (2015) -
Diabetes Has Gotten Pretty Darn Complicated
por: Skolnik, Neil, et al.
Publicado: (2015)